Go Pro

JPMorgan Chase & Co. (NYSE:JPM) Trading 1.7% Higher - Still a Buy?

JPMorgan Chase & Co. logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • JPMorgan shares rose 1.7% to $362.11, supported by higher Treasury yields that may boost net interest income and by investor rotation into large, financially strong banks.
  • The bank reported strong quarterly results, with EPS of $6.14 beating the $5.59 estimate and revenue of $58.02 billion exceeding expectations; analysts maintain a “Moderate Buy” consensus, though the average target is $359.96.
  • Longer-term growth opportunities include its Kinexys payments and blockchain platform and expanded natural-capital business, while legal costs and increasing fixed-income competition remain key risks.
  • MarketBeat previews the top five stocks to own by October 1st.

JPMorgan Chase & Co. (NYSE:JPM) shares traded up 1.7% during trading on Thursday . The stock traded as high as $362.85 and last traded at $362.11. 5,007,900 shares were traded during mid-day trading, a decline of 47% from the average daily volume of 9,385,148 shares. The stock had previously closed at $356.22.

Key Stories Impacting JPMorgan Chase & Co.

Here are the key news stories impacting JPMorgan Chase & Co. this week:

  • Positive Sentiment: Higher Treasury yields support earnings. JPMorgan’s outlook is being helped by the 10-year Treasury yield reaching 4.8%; higher rates can expand net interest income, which was recently reported at $25.6 billion, up 10%. JPMorgan Rises as 10-Year Treasury Yield Hits 4.8%
  • Positive Sentiment: Investors are rotating toward major banks. Expectations for higher rates, combined with concerns about stretched artificial-intelligence valuations, are directing capital toward financially strong institutions such as JPMorgan. Expectations of Rising Rates and Worries About AI Have Investors Piling Into Big Bank Stocks
  • Positive Sentiment: Payments and asset-management initiatives add longer-term growth potential. JPMorgan’s Kinexys blockchain platform is gaining traction in settlement and payments, while the rebranding of Campbell Global as J.P. Morgan Natural Capital positions the firm for growing institutional interest in nature-based assets. Will Kinexys Fuel JPMorgan’s Next Leg of Payments Growth?
  • Neutral Sentiment: JPMorgan has reduced financing to Jane Street as the quantitative trading firm expands in U.S. Treasury market-making. The move may limit JPMorgan’s exposure to a growing competitor, but also highlights intensifying competition in fixed-income trading. JPMorgan curbed lending to Jane Street as trading firm muscled into bonds
  • Negative Sentiment: Legal expenses remain an overhang. JPMorgan is seeking to stay a $20 million fee order connected to the Frank/Javice litigation, keeping investor attention on potential costs and legal liabilities. JPMorgan Seeks Stay Of $20M Javice, Amar Fee Order

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on JPM shares. UBS Group raised their price target on JPMorgan Chase & Co. from $384.00 to $400.00 and gave the company a "buy" rating in a research report on Monday, August 3rd. Zacks Research raised JPMorgan Chase & Co. from a "hold" rating to a "strong-buy" rating in a research report on Thursday, July 16th. Weiss Ratings downgraded JPMorgan Chase & Co. from a "buy (b+)" rating to a "buy (b)" rating in a research note on Wednesday, August 19th. Barclays raised their target price on JPMorgan Chase & Co. from $391.00 to $420.00 and gave the company an "overweight" rating in a report on Wednesday, July 15th. Finally, Keefe, Bruyette & Woods lifted their price target on JPMorgan Chase & Co. from $370.00 to $384.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 15th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $359.96.

View Our Latest Stock Analysis on JPM

JPMorgan Chase & Co. Trading Up 1.7%

The firm has a market cap of $962.56 billion, a P/E ratio of 15.51, a PEG ratio of 1.46 and a beta of 0.98. The company's 50 day moving average is $348.76 and its two-hundred day moving average is $319.75. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.85 and a quick ratio of 0.85.

JPMorgan Chase & Co. (NYSE:JPM - Get Free Report) last announced its quarterly earnings data on Tuesday, July 14th. The financial services provider reported $6.14 EPS for the quarter, topping analysts' consensus estimates of $5.59 by $0.55. The company had revenue of $58.02 billion during the quarter, compared to the consensus estimate of $50.72 billion. JPMorgan Chase & Co. had a return on equity of 18.23% and a net margin of 21.86%.The company's quarterly revenue was up 27.7% on a year-over-year basis. During the same quarter last year, the company earned $4.96 EPS. On average, sell-side analysts predict that JPMorgan Chase & Co. will post 24.28 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Robin Leopold sold 2,500 shares of the firm's stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $361.41, for a total transaction of $903,525.00. Following the completion of the transaction, the insider directly owned 73,547 shares of the company's stock, valued at approximately $26,580,621.27. This trade represents a 3.29% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Stacey Friedman sold 5,467 shares of the company's stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $330.73, for a total transaction of $1,808,100.91. Following the completion of the sale, the general counsel directly owned 40,961 shares in the company, valued at approximately $13,547,031.53. The trade was a 11.78% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.41% of the stock is owned by insiders.

Hedge Funds Weigh In On JPMorgan Chase & Co.

Several hedge funds and other institutional investors have recently modified their holdings of JPM. Timmons Wealth Management LLC bought a new stake in JPMorgan Chase & Co. during the fourth quarter worth about $27,000. MBM Wealth Consultants LLC bought a new position in shares of JPMorgan Chase & Co. in the first quarter valued at approximately $29,000. Caitong International Asset Management Co. Ltd bought a new position in shares of JPMorgan Chase & Co. in the fourth quarter valued at approximately $32,000. Aventus Investment Advisors Inc. acquired a new position in shares of JPMorgan Chase & Co. in the 2nd quarter worth approximately $33,000. Finally, Osbon Capital Management LLC bought a new stake in JPMorgan Chase & Co. during the 4th quarter worth approximately $35,000. Institutional investors own 71.55% of the company's stock.

JPMorgan Chase & Co. Company Profile

(Get Free Report)

JPMorgan Chase & Co NYSE: JPM is a diversified global financial services firm headquartered in New York City. The company provides a wide range of banking and financial products and services to consumers, small businesses, corporations, governments and institutional investors worldwide. Its operations span retail banking, commercial lending, investment banking, asset management, payments and card services, and treasury and securities services.

The firm's principal business activities are organized across several core lines: Consumer & Community Banking, which offers deposit accounts, mortgages, auto loans, credit cards and branch and digital banking under the Chase brand; Corporate & Investment Banking, which provides capital markets, advisory, underwriting, trading and risk management services; Commercial Banking, delivering lending, treasury and capital solutions to middle-market and corporate clients; and Asset & Wealth Management, which offers investment management, private banking and retirement services to institutions and high-net-worth individuals.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in JPMorgan Chase & Co. Right Now?

Before you consider JPMorgan Chase & Co., you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and JPMorgan Chase & Co. wasn't on the list.

While JPMorgan Chase & Co. currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines